Cell-Free DNA Analysis Distinguishes Recurrent From Primary Breast Cancer
Kumamoto University researchers have developed a blood test that analyzes nucleosome structures in cell-free DNA to detect breast cancer recurrence.
Read MorePosted by CLP Edit Staff | Aug 31, 2026 | Breast |
Kumamoto University researchers have developed a blood test that analyzes nucleosome structures in cell-free DNA to detect breast cancer recurrence.
Read MorePosted by CLP Edit Staff | Aug 27, 2026 | Coagulation Testing |
Precision BioLogic reports rising demand for its chromogenic factor VIII assay as labs prepare for new hemophilia A therapies, including bispecific antibodies submitted for FDA review by Novo Nordisk.
Read MorePosted by CLP Edit Staff | Aug 27, 2026 | Kidney Disease, Transfusion & Transplantation Tests |
A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.
Read MorePosted by CLP Edit Staff | Aug 19, 2026 | Lab Automation |
The FDA has authorized Aletta, the first standalone robotic device for automated blood draws in outpatient settings, allowing one phlebotomist to oversee up to three devices to help address workforce shortages.
Read MorePosted by CLP Edit Staff | Aug 17, 2026 | Hematology Instrumentation |
Algocyte has launched the PROXIMA Mobile Health Station, a portable device that uses AI and sensors for at-home blood analysis from finger-prick samples, with UKCA regulatory approval and ongoing evaluation.
Read More